⌘K

Login Start Free

Home/Filings/4/0001193125-25-305662

4//SEC Filing

Rothfuss Cristin 4

Accession 0001193125-25-305662

CIK 0000873303other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 8:02 PM ET

Size

4.9 KB

Accession

0001193125-25-305662

Insider Transaction Report

Form 4

Period: 2025-11-28

Sarepta Therapeutics, Inc.SRPT

Rothfuss Cristin

EVP, General Counsel

Transactions

Tax Payment
Common Stock
2025-11-28$21.12/sh−229$4,836→ 139,756 total

Footnotes (1)

[F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1

filerCIK 0002046214

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 8:02 PM ET
Size: 4.9 KB

View on SEC.gov